Pasithea Therapeutics (KTTA) Earnings Date & Reports
Pasithea Therapeutics Corp is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KTTA is expected to report earnings to rise 31.25% to -20 cents per share on December 02
Q3'26
Est.
$-0.21
Q2'26
Est.
$-0.16
Q4'25
Missed
by $0.61
Q1'23
Est.
$-0.17
Q4'22
Est.
$-0.18
The last earnings report on September 02 showed earnings per share of -15 cents, meeting the estimate of -15 cents. With 84.48K shares outstanding, the current market capitalization sits at 17.18M.